Key Takeaways
A federal judge on May 20 granted Lunai Bioworks’ (Nasdaq: LNAI) motion for expedited discovery to identify up to 50 “John Doe” defendants accused of illegal naked short selling. The ruling from the U.S. District Court for the District of Delaware is a key first step in the company’s lawsuit against the unnamed traders.
"This is the first step to... pursuing substantial damages from the 'naked' short sellers who have caused real market harm to Lunai and its shareholders," Jacob Frenkel, co-lead counsel and Securities Enforcement Practice Chair at Dickinson Wright, said in a statement.
The order allows Lunai to immediately issue discovery requests to broker-dealers to obtain trading data and the identities of investors who held naked short positions in the company's stock from late 2025 through the first half of 2026. The court found "good cause" for the accelerated timeline, noting Lunai had established a prima facie case for its claims.
The legal action, filed May 11 by law firms Dickinson Wright and Fox Rothschild, alleges stock manipulation and securities fraud. If successful, it could halt the alleged trading activity and recover significant damages for the AI-driven precision medicine company. Frenkel, a former SEC enforcement lawyer, noted that the conduct could lead to amending the complaint to include civil RICO claims, which would multiply potential damages.
In its ruling, the court recognized that information on the traders is "uniquely held by market infrastructure entities and market participants," making the early discovery essential. Sidney Liebesman, co-lead counsel and a Senior Litigation Partner at Fox Rothschild, added that the court "appreciated both the gravity and time sensitivity of the need to commence discovery."
The complaint asserts three counts: securities fraud, market manipulation, and the intentional tort of wire fraud. Lunai, a Sacramento-based company, develops AI-driven platforms for precision medicine and biodefense countermeasures.
The court's decision provides Lunai with a critical tool to fight alleged market manipulation that it claims has harmed the company and its investors. Investors will now watch for the identities of the "John Doe" defendants to be revealed and for any subsequent legal proceedings, including a potential amendment to the complaint to add civil RICO claims.
This article is for informational purposes only and does not constitute investment advice.
